Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer.
JHEP Rep
; 5(3): 100648, 2023 Mar.
Article
em En
| MEDLINE
| ID: mdl-36699667
AUC, area under receiver-operating characteristic curve; BBTD, benign biliary tract disease; BP, best point; BTC, biliary tract cancer; CA19-9, carbohydrate antigen 19-9; CAIX, carbonic anhydrase IX; CASP8, caspase 8; CCA, cholangiocarcinoma; CCL, chemokine (C-C motif) ligand; CXCR, C-X-C motif chemokine; EDTA, ethylenediaminetetraacetic acid; GBC, gall bladder cancer; I-O, immuno-oncology; IL, interleukin; MMP-, matrix metalloproteinase-; NPX, normalized protein expression; TME, tumor microenvironment; biliary tract cancer; blood protein assay; cholangiocarcinoma; dCCA, distal cholangiocarcinoma; diagnosis; gall bladder cancer; iCCA, intrahepatic cholangiocarcinoma; multi-biomarker signature; pCCA, perihilar cholangiocarcinoma
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
JHEP Rep
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Dinamarca